enrofloxacin has been researched along with Sepsis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, S; Francis, KP; Hod, EA; Karolewski, B; Papich, MG; Prestia, KA; Slate, AR | 1 |
| Buck, LT; Harapa, GM; Ramaglia, V; White, N | 1 |
| Devriese, LA; Gevaert, D; Haesebrouck, F; Okerman, L; Uyttebroek, E | 1 |
3 other study(ies) available for enrofloxacin and Sepsis
| Article | Year |
|---|---|
Efficacy of enrofloxacin in a mouse model of sepsis.
Topics: Administration, Intravenous; Administration, Oral; Animals; Anti-Bacterial Agents; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Male; Mice; Sepsis | 2014 |
Bacterial infection and tissue-specific Hsp72, -73 and -90 expression in western painted turtles.
Topics: Animals; Brain; Chloramphenicol; Dermatitis; Enrofloxacin; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Heart; Heat-Shock Proteins; Heat-Shock Response; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Liver; Male; Muscle, Skeletal; Myocardium; Organ Specificity; Quinolones; Sepsis; Turtles | 2004 |
In vivo activity of orally administered antibiotics and chemotherapeutics against acute septicaemic pasteurellosis in rabbits.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Drug Evaluation, Preclinical; Enrofloxacin; Fluoroquinolones; Pasteurella Infections; Quinolones; Rabbits; Sepsis | 1990 |